Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to $1.2 million.

  • Standard Biotools' Other Non-Current Liabilities fell 2052.98% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 2052.98%. This contributed to the annual value of $1.1 million for FY2024, which is 28.17% down from last year.
  • As of Q3 2025, Standard Biotools' Other Non-Current Liabilities stood at $1.2 million, which was down 2052.98% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Other Non-Current Liabilities ranged from a high of $3.5 million in Q1 2025 and a low of $276000.0 during Q2 2021
  • For the 5-year period, Standard Biotools' Other Non-Current Liabilities averaged around $1.3 million, with its median value being $1.2 million (2022).
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first plummeted by 6318.61% in 2023, then surged by 41272.73% in 2024.
  • Over the past 5 years, Standard Biotools' Other Non-Current Liabilities (Quarter) stood at $882000.0 in 2021, then grew by 8.96% to $961000.0 in 2022, then rose by 10.82% to $1.1 million in 2023, then dropped by 0.28% to $1.1 million in 2024, then grew by 12.99% to $1.2 million in 2025.
  • Its Other Non-Current Liabilities was $1.2 million in Q3 2025, compared to $1.2 million in Q2 2025 and $3.5 million in Q1 2025.